“…Second, expression of ATF3 has been demonstrated to alter a variety of cellular processes relevant to cancer progression including cell cycle, cell death, angiogenesis and metastasis (Hai and Hartman, 2001;Okamoto et al, 2006). Third, ATF3 expression can be regulated transcriptionally by a variety of signalling pathways or transcription factors, including nuclear factor kappa B (Hartman et al, 2004), EGR-1 (Bottone et al, 2005), by p53-dependent and -independent pathways (Amundson et al, 1999;Fan et al, 2002), and by the c-Jun NH 2 -terminal kinase (JNK) (Cai et al, 2000), which is activated by MKK7 (Tournier et al, 1997). In addition to promoter activation, ATF3 mRNA can also accumulate as a result of mRNA stabilization (Liang et al, 1996).…”